Concepedia
Statistics
Publications
10
Citations
372
H-Index
Active since
2006
Affiliations
Boehringer Ingelheim (United States)(Current)
Evotec (Germany)
Boehringer Ingelheim (Germany)
Evotec (United Kingdom)
Evotec (United States)
Angela Berry is an author at Boehringer Ingelheim (United States) specializing in drug discovery, pharmacology, and medicine.
Top concepts
MedicinePharmacologyDrug DiscoveryPharmacotherapyBiochemistryMolecular PharmacologyNeuropharmacologyNatural SciencesMedicinal ChemistryCannabinoid Pharmacology
Publications per year
2006–2019
In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease
Brian L. Lin, Damian Matera, Julia F. Doerner et al. · Proceedings of the National Academy of Sciences · 2019 · 143 citations · Full text
Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β: Part I: Hit-to-Lead Strategies
Tina M. Morwick, Angela Berry, Janice R. Brickwood et al. · Journal of Medicinal Chemistry · 2006 · 67 citations · Full text
Identification of Highly Efficacious Glucocorticoid Receptor Agonists with a Potential for Reduced Clinical Bone Side Effects
Christian Harcken, Doris Riether, Daniel Kuzmich et al. · Journal of Medicinal Chemistry · 2014 · 31 citations · Full text
Sclerostin, Glucocorticoid, Orthopaedic Surgery +17
Discovery and Optimization of p38 Inhibitors via Computer-Assisted Drug Design
Daniel R. Goldberg, Ming‐Hong Hao, Kevin Qian et al. · Journal of Medicinal Chemistry · 2007 · 24 citations · Full text
1,4-Diazepane compounds as potent and selective CB2 agonists: Optimization of metabolic stability
Doris Riether, Lifen Wu, Pier F. Cirillo et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 21 citations · Full text
Cannabis Use, Molecular Pharmacology, Metabolic Stability +11
1–5 of 10